Table of Contents

Pharmaceuticals, Volume 6, Issue 2 (February 2013), Pages 124-286

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Readerexternal link to open them.
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-7

Research

Jump to: Review

p. 184-203
by , , , , ,  and
Pharmaceuticals 2013, 6(2), 184-203; doi:10.3390/ph6020184
Received: 1 November 2012; in revised form: 29 January 2013 / Accepted: 30 January 2013 / Published: 6 February 2013
Show/Hide Abstract | Cited by 3 | PDF Full-text (2068 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Cell-penetrating Peptides)
p. 204-222
by , , , , , ,  and
Pharmaceuticals 2013, 6(2), 204-222; doi:10.3390/ph6020204
Received: 19 November 2012; in revised form: 22 January 2013 / Accepted: 23 January 2013 / Published: 6 February 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (2818 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Cell-penetrating Peptides)

Review

Jump to: Research

p. 124-160
by , ,  and
Pharmaceuticals 2013, 6(2), 124-160; doi:10.3390/ph6020124
Received: 20 December 2012; in revised form: 10 January 2013 / Accepted: 22 January 2013 / Published: 28 January 2013
Show/Hide Abstract | PDF Full-text (594 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 161-183
by  and
Pharmaceuticals 2013, 6(2), 161-183; doi:10.3390/ph6020161
Received: 7 January 2013; in revised form: 17 January 2013 / Accepted: 29 January 2013 / Published: 4 February 2013
Show/Hide Abstract | Cited by 2 | PDF Full-text (581 KB) | HTML Full-text | XML Full-text
p. 223-250
by , ,  and
Pharmaceuticals 2013, 6(2), 223-250; doi:10.3390/ph6020223
Received: 19 December 2012; in revised form: 19 January 2013 / Accepted: 1 February 2013 / Published: 6 February 2013
Show/Hide Abstract | Cited by 5 | PDF Full-text (1276 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 251-268
by , ,  and
Pharmaceuticals 2013, 6(2), 251-268; doi:10.3390/ph6020251
Received: 30 November 2012; in revised form: 29 January 2013 / Accepted: 29 January 2013 / Published: 6 February 2013
Show/Hide Abstract | Cited by 4 | PDF Full-text (304 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue NMDA Receptor Antagonists for Treatment of CNS Disorders)
p. 269-286
by ,  and
Pharmaceuticals 2013, 6(2), 269-286; doi:10.3390/ph6020269
Received: 20 December 2012; in revised form: 23 January 2013 / Accepted: 5 February 2013 / Published: 7 February 2013
Show/Hide Abstract | PDF Full-text (735 KB) | HTML Full-text | XML Full-text
Select/unselect all
Displaying article 1-7
Select articles Export citation of selected articles as:
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert